The initial success of the copyright undeniably transformed the pharmaceutical landscape, but investing in companies primarily reliant on off-patent versions presents a challenging picture. Although early returns were https://pharma372205.fitnell.com/82958868/sildenafil-and-big-pharma-a-risky-investment